1. AVGO: Most interesting. AI growth is expanding beyond NVIDIA into custom chips and networking.
2.DE: Two upgrades suggest agriculture may be recovering, but DE is cyclical.
3. DELL: Benefits from growing AI server and data-center demand.
4. SHEL: Higher oil prices are supportive, but oil is unpredictable.
5. Biotech: Higher risk because clinical failures can cause huge price drops.
My preference for long-term investing:
AVGO 50%
DE 30%
DELL 10%
SHEL 5%
Biotech 5%
The key lesson: Analyst upgrades are not guaranteed buy signals. For 5–20 years, focus more on revenue, profit, cash flow, debt and competitive advantage.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
